EXTH-23. COMBINED EFFECTS OF NICLOSAMIDE AND TEMOZOLOMIDE AGAINST HUMAN GLIOBLASTOMA TUMORSPHERES

PURPOSE: Glioblastoma (GBM) is the most aggressive type of brain tumor and has poor survival outcomes, even after a combination of surgery, radiotherapy, and chemotherapy. Temozolomide is the only agent that has been shown to be effective against GBM, suggesting that combination of temozolomide with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Cheol Oh, Hyeong, Yoo, Jihwan, Shim, Jin-Kyoung, Park, Junseong, Lee, Ji-hyun, Joo Choi, Ran, sil Kim, Hyun, hee Kim, Nam, Hyung Moon, Ju, Hyun Kim, Eui, Hee Chang, Jong, Kang, Seok-Gu, In Yook, Jong
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Experimental Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847496/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.357
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados